EHMT2 and Anxiety: Several preclinical studies demonstrated anxiety-related behavioral abnormalities and cognitive impairments associated with conditional G9a/GLP deficiency and pharmacological inhibition of G9a activity in the brain (Schaefer et al., 2009; Wang et al., 2018).